Clearance Summary
Theranova Dialyzers, Theranova 400 Dialyzer, Theranova 500 Dialyzer received FDA 510(k) clearance under submission number DEN190042, sponsored by Baxter Healthcare Corporation. The device was reviewed via the Direct premarket notification pathway and assigned to the Gastroenterology, Urology review panel. The statutory decision date of record is 2020-08-28.
- Submission: DEN190042
- Applicant / Sponsor: Baxter Healthcare Corporation
- Clearance pathway: Direct
- Review panel: Gastroenterology, Urology
- Device class: Class II
- Regulation citation: 21 CFR 876.5862
- Decision date: 2020-08-28
Classification & Regulation
This clearance is catalogued under FDA product code QAX and 21 CFR 876.5862, within the Gastroenterology, Urology review panel as a Class II device.